SCHEMBL31663511

SCHEMBL31663511

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ATM Q13315 1/20 0.49
AKR1C4 P17516 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
HSD17B10 Q99714 1/20 0.38
HDAC4 P56524 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2C9 P11712 1/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663539 0.94 KDM4E (0.39) KDM4EL3MBTL1ATMBCHEACHE
SCHEMBL23679400 0.92 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL12109712 0.92 KDM4E (0.53) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL31663538 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL31663593 0.92 L3MBTL1 (0.44) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL31663574 0.90 KDM4E (0.45) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL10098596 0.90 L3MBTL1 (0.40) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL13133927 0.90 AVPR1A (0.45) KDM4EL3MBTL1ATMHSD17B10ALDH1A1
SCHEMBL17178965 0.90 KDM4E (0.50) KDM4EL3MBTL1ATMAKR1C4AKR1C3
SCHEMBL25920142 0.90 KDM4E (0.50) KDM4EL3MBTL1ATMAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885L3MBTL1 1198/4885ATM 1817/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885L3MBTL1 1198/4885ATM 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.